Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 117
Infectious Diseases Drugs 88
Endocrine and Metabolic Disorders Drugs 75
Central Nervous System Drugs 59
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 45
Drug Discovery 41
Diabetes Drugs 41
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 37
Urological Disorders Drugs 35
Clinical Trials 33
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Cardiovascular Drugs 26
Musculoskeletal Disorders Drugs 26
Leukemia Drugs 25
Liver and Kidney Disorders Drugs 25
Immunosuppressive Drugs 23
Antibiotics 22
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Stem Cells 19
Surgical Procedures 19
Oncology 18
Analgesics 17
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Medical Devices 13
Infusions and Injectables 12
Diagnostics 12
Drug Delivery 12
Bladder Cancer Drugs 11
Dermatology 11
Healthcare Services 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Respiratory Drugs 8
Pharmaceutical Manufacturing 8
Pulmonary Medicine 7
Neurology 7
Lymphoma Drugs 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Biomaterials 6
Hearing Aids and Implants 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Needles and Syringes 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Endocrinology 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

1,131 Results (Page 5 of 57)
- Relevance
  Sort by

Benign Prostatic Hyperplasia Treatment Market - Global Forecast 2026-2032

 Report
September 2026
198 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Prostate Cancer Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
192 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Enzalutamide Tablets Market - Global Forecast 2026-2032

 Report
September 2026
187 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Benign Prostatic Hyperplasia Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Prostate Cancer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
124 Pages
Global

From

€4409EUR$4,750USD£3,678GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Mitoxantrone Hydrochloride Market - Global Forecast 2026-2032

 Report
September 2026
180 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Castration-resistant Prostate Cancer Drugs Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Enzalutamide Soft Capsules Market - Global Forecast 2026-2032

 Report
September 2026
198 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Enzalutamide Drugs Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

 Report
February 2025
315 Pages
Global

From

€4454EUR$4,799USD£3,716GBP

Benign Prostatic Hyperplasia Treatment Market Size, Share, Trends and Forecast by Treatment Type, and Region, 2026-2034

 Report
March 2026
145 Pages
Global

From

€3712EUR$3,999USD£3,096GBP

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2026

 Report
September 2026
1500 Pages
Global

From

€4636EUR$4,995USD£3,867GBP

Prostate Cancer Therapeutics Market

 Report
September 2025
150 Pages
Global

From

€4130EUR$4,450USD£3,445GBP

Schizophrenia Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
184 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Consumer Healthcare Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4168EUR$4,490USD£3,476GBP

Antimicrobial Therapeutics - Global Strategic Business Report

 Report
November 2026
494 Pages
Global

From

€5430EUR$5,850USD£4,529GBP

Immunosuppressant Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
110 Pages
Global

From

€4409EUR$4,750USD£3,678GBP

Biosimilars and Follow-On Biologics Market Report 2024-2034

 Report
May 2024
391 Pages
Global

From

€5397EUR$6,018USD£4,350GBP

Immunosuppressant Drugs Market - Global Forecast 2026-2032

 Report
September 2026
192 Pages
Global

From

€3291EUR$3,545USD£2,745GBP

€3656EUR$3,939USD£3,050GBP

Nivolumab Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4168EUR$4,490USD£3,476GBP

1,131 Results (Page 5 of 57)
- 1
- 3
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.